MXPA03003146A - Extended release erythromycin derivatives. - Google Patents

Extended release erythromycin derivatives.

Info

Publication number
MXPA03003146A
MXPA03003146A MXPA03003146A MXPA03003146A MXPA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A
Authority
MX
Mexico
Prior art keywords
extended release
long chain
erythromycin derivatives
erythromycin derivative
release erythromycin
Prior art date
Application number
MXPA03003146A
Other languages
Spanish (es)
Inventor
Donald J Treacy Jr
Original Assignee
Advancis Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancis Pharmaceuticals filed Critical Advancis Pharmaceuticals
Publication of MXPA03003146A publication Critical patent/MXPA03003146A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

An extended release pharmaceutical composition comprised of an erythromycin derivative and non-polymer material for providing for extended release, in particular, a member selected from the group consisting of clays, long chain hydrocarbons, long chain carboxylic acids, long chain carboxylic acid esters, long chain alcohols, and mixtures thereof, with said member being present in an amount to provide for extended release of the erythromycin derivative.
MXPA03003146A 2000-10-13 2001-10-12 Extended release erythromycin derivatives. MXPA03003146A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68998800A 2000-10-13 2000-10-13
US0133055 2001-10-12

Publications (1)

Publication Number Publication Date
MXPA03003146A true MXPA03003146A (en) 2004-12-06

Family

ID=24770642

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003146A MXPA03003146A (en) 2000-10-13 2001-10-12 Extended release erythromycin derivatives.

Country Status (6)

Country Link
EP (1) EP1333807A4 (en)
JP (1) JP2004528272A (en)
AU (1) AU2002239232A1 (en)
CA (1) CA2425688A1 (en)
MX (1) MXPA03003146A (en)
WO (1) WO2002038577A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
JP2007502294A (en) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション Antibiotic preparations, their use and preparation
EP1811986B1 (en) * 2004-11-04 2014-03-26 XenoPort, Inc. Gabapentin prodrug sustained release oral dosage forms

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
JPS49107855A (en) * 1973-02-03 1974-10-14
JP2528652B2 (en) * 1987-03-30 1996-08-28 エスエス製薬株式会社 Long-acting cefradine formulation
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
JP3265680B2 (en) * 1992-03-12 2002-03-11 大正製薬株式会社 Oral pharmaceutical composition
JPH07267850A (en) * 1994-03-28 1995-10-17 Eisai Co Ltd Medicine composition prevented in unpleasant taste and method for producing the same
EP0826376B1 (en) * 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition for oral administration
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US5780604A (en) * 1997-09-26 1998-07-14 Abbott Laboratories 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
JP2000169364A (en) * 1998-09-30 2000-06-20 Taisho Pharmaceut Co Ltd Granule for oral pharmaceutical preparation
CN1343128B (en) * 1999-03-17 2010-04-21 第一制药株式会社 Medicinal compositions
SI20244A (en) * 1999-05-19 2000-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Melt granulation

Also Published As

Publication number Publication date
EP1333807A4 (en) 2005-06-29
WO2002038577A3 (en) 2002-09-19
CA2425688A1 (en) 2002-05-16
WO2002038577A2 (en) 2002-05-16
EP1333807A2 (en) 2003-08-13
JP2004528272A (en) 2004-09-16
AU2002239232A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
DE60006070D1 (en) PYRAZOL CARBOXYLIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF
AU2002229140A1 (en) Controlled release pharmaceutical composition
BR0106100B1 (en) Fixed plaster composition, article, and method for preparing a fixed plaster composition.
IL154507A0 (en) Process for making n-aryl-anthranilic acids and their derivatives
DE69902535D1 (en) PHENOXYPROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EE05194B1 (en) Aminodicarboxylic acid derivatives with pharmaceutical properties
DE50102147D1 (en) ACYLPHENYL URINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
ID26738A (en) PROCESS FOR PRODUCING ACROLEINE AND ACRYLIC ACID
DE60325461D1 (en) PHARMACEUTICAL GRANULAR COMPOSITIONS WITH IMMEDIATE RELEASE AND CONTINUOUS PROCESS FOR THEIR PREPARATION
AU2001278980A1 (en) Coumarin derivatives useful as tnfalpha inhibitors
ATE296535T1 (en) AQUEOUS FORMULATIONS AND METHOD FOR THE PRODUCTION THEREOF
AU2001236678A1 (en) Adamantyl derivatives as anti-cancer agents
CA2313878A1 (en) Composition for suppressing behavior problems of pets
DE60304599D1 (en) PYRIDOPYRIMIDINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF
AU2001272293A1 (en) Device for administering an injectable product
ID29673A (en) PROCESS FOR RESORSINOL DRIVING
MXPA03002901A (en) Propionic acid derivatives with ppar-alpha activating properties.
DE60113888D1 (en) Packaging with means of proving its integrity
ID29229A (en) COMPOSITION AND PROCESS FOR MOVING ACID GAS
MXPA03003146A (en) Extended release erythromycin derivatives.
DE60131637D1 (en) GRANULAR DETERGENT COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
AU2002222750A1 (en) Pharmaceutical composition for intramuscular injection containing loxoprofen
ATE358470T1 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
ATE244246T1 (en) PYRIDOTHIENODIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
ID17326A (en) 4-ARILBUTIRATE ACID-SUBSTITUTED ACID DRUGS AS METALLOPROTEASE MATRIX INHIBITORS